Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$56.94 USD

56.94
5,112,835

+0.47 (0.83%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (235 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Best Growth Stocks to Buy for November 19th

HHR, CVS, PSX, and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 19, 2021.

Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon

Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon

Sheraz Mian headshot

Top Research Reports for Microsoft, Berkshire Hathaway & Oracle

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Berkshire Hathaway Inc. (BRK.B), and Oracle Corporation (ORCL).

Urmimala Biswas headshot

2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and RAD are likely to gain the most. However, reimbursement challenges are hurting the overall industry health.

CVS Health (CVS) Q3 Earnings Top Estimates, 2021 EPS View Up

Strength in all three operating segments drove CVS Health's (CVS) revenues in the third quarter of 2021.

CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 10.06% and 5.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Sprouts Farmers (SFM) to Post Q3 Earnings: Key Aspects to Note

Sprouts Farmers (SFM) third-quarter performance is likely to have been affected by moderation of at-home dining trends.

Is a Surprise Coming for CVS Health (CVS) This Earnings Season?

CVS Health (CVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?

CVS Health's (CVS) consumer-centric digital approach to administering vaccines across the nation is expected to have strongly contributed to its Q3 performance.

Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Retail and Wholesale

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $88.32, marking a +0.73% move from the previous day.

CVS Health (CVS) Gains But Lags Market: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $87.68, marking a +0.18% move from the previous day.

Here's Why You Should Hold on to Walgreens Boots (WBA) for Now

Investors are optimistic about Walgreens Boots (WBA) given its better-than-expected fourth-quarter fiscal 2021 results and strategic alliances.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $84.48, marking a -1.58% move from the previous day.

NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax

Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?

Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?

CVS Health (CVS) Stock Moves -0.11%: What You Should Know

CVS Health (CVS) closed the most recent trading day at $84.28, moving -0.11% from the previous trading session.

Quidel Corporation (QDEL) Reports Solid Preliminary Q3 Revenues

Quidel's (QDEL) revenue growth in the third quarter is likely to have been boosted by robust sales of its SARS-related products.

Mark Vickery headshot

Top Analyst Reports for Pfizer, American Tower & Intuitive Surgical

Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), American Tower Corporation (AMT), and Intuitive Surgical, Inc. (ISRG).

CVS Health (CVS) Stock Moves -0.31%: What You Should Know

CVS Health (CVS) closed at $83.81 in the latest trading session, marking a -0.31% move from the prior day.

Here's Why You Should Retain CVS Health (CVS) Stock For Now

Investors are optimistic about CVS Health (CVS) on growth in the company's specialty digital solutions and a bullish 2021 outlook.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed at $85.74 in the latest trading session, marking a +1.22% move from the prior day.